See more : Isgec Heavy Engineering Limited (ISGEC.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangzhou Kingmed Diagnostics Group Co., Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- CAMP4 Therapeutics Corporation (CAMP) Income Statement Analysis – Financial Results
- EnQuest PLC (ENQUF) Income Statement Analysis – Financial Results
- iMotion Automotive Tech (1274.HK) Income Statement Analysis – Financial Results
- Hauman Technologies Corp. (6218.TWO) Income Statement Analysis – Financial Results
- S.R. Industries Limited (SRIND.BO) Income Statement Analysis – Financial Results
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)
About Guangzhou Kingmed Diagnostics Group Co., Ltd.
Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.54B | 15.48B | 11.94B | 8.24B | 5.27B | 4.53B | 3.79B | 3.22B | 2.39B | 1.84B | 1.36B | 977.20M |
| Cost of Revenue | 5.42B | 8.80B | 6.30B | 4.40B | 3.19B | 2.77B | 2.24B | 1.86B | 1.29B | 1.00B | 758.75M | 591.86M |
| Gross Profit | 3.12B | 6.67B | 5.65B | 3.85B | 2.08B | 1.76B | 1.55B | 1.36B | 1.10B | 834.94M | 597.32M | 385.34M |
| Gross Profit Ratio | 36.48% | 43.13% | 47.29% | 46.69% | 39.48% | 38.83% | 40.96% | 42.35% | 45.92% | 45.43% | 44.05% | 39.43% |
| Research & Development | 418.91M | 632.62M | 517.93M | 397.17M | 324.02M | 290.85M | 255.98M | 238.21M | 221.02M | 161.13M | 115.75M | 42.61M |
| General & Administrative | 712.45M | 388.77M | 364.04M | 244.39M | 185.41M | 170.68M | 167.77M | 114.84M | 94.59M | 173.36M | 235.42M | 130.42M |
| Selling & Marketing | 1.02B | 1.51B | 1.44B | 992.63M | 806.40M | 703.68M | 638.23M | 591.60M | 456.52M | 345.25M | 271.90M | 185.12M |
| SG&A | 2.09B | 1.90B | 1.80B | 1.24B | 991.81M | 874.36M | 805.99M | 706.45M | 551.11M | 518.61M | 507.32M | 315.54M |
| Other Expenses | 0.00 | 542.10M | 452.75M | 316.36M | 266.90M | 8.82M | 9.28M | 42.12M | 26.87M | 12.39M | 12.45M | 10.48M |
| Operating Expenses | 2.36B | 3.08B | 2.77B | 1.95B | 1.58B | 1.40B | 1.25B | 1.14B | 901.36M | 771.53M | 508.27M | 316.61M |
| Cost & Expenses | 7.78B | 11.88B | 9.07B | 6.35B | 4.77B | 4.17B | 3.49B | 2.99B | 2.19B | 1.77B | 1.27B | 908.47M |
| Interest Income | 25.39M | 30.40M | 21.53M | 13.76M | 9.97M | 5.79M | 3.09M | 1.34M | 1.61M | 504.60K | 12.20M | 7.15M |
| Interest Expense | 20.39M | 23.65M | 27.55M | 29.26M | 37.64M | 35.24M | 35.27M | 29.55M | 28.91M | 19.13M | 0.00 | 0.00 |
| Depreciation & Amortization | 678.57M | 618.87M | 532.08M | 348.64M | 309.90M | 263.52M | 204.34M | 147.52M | 67.91M | 47.61M | 36.49M | 28.16M |
| EBITDA | 1.45B | 3.98B | 3.20B | 2.12B | 789.91M | 623.06M | 481.55M | 409.58M | 300.38M | 118.99M | 125.54M | 96.90M |
| EBITDA Ratio | 17.01% | 26.65% | 27.48% | 26.27% | 15.49% | 13.17% | 13.10% | 12.27% | 12.17% | 6.69% | 9.58% | 10.36% |
| Operating Income | 759.76M | 3.35B | 2.78B | 1.82B | 484.03M | 311.96M | 262.55M | 188.98M | 162.78M | 40.27M | 72.06M | 56.97M |
| Operating Income Ratio | 8.90% | 21.63% | 23.25% | 22.04% | 9.19% | 6.89% | 6.92% | 5.87% | 6.81% | 2.19% | 5.31% | 5.83% |
| Total Other Income/Expenses | -19.47M | -26.50M | -29.21M | -6.39M | 15.14M | 8.82M | 9.28M | 12.75M | 27.19M | -50.71M | -5.03M | -1.44M |
| Income Before Tax | 740.29M | 3.32B | 2.75B | 1.81B | 495.72M | 320.78M | 271.82M | 230.83M | 189.15M | 52.25M | 84.02M | 67.30M |
| Income Before Tax Ratio | 8.67% | 21.46% | 23.01% | 21.96% | 9.41% | 7.09% | 7.17% | 7.17% | 7.92% | 2.84% | 6.20% | 6.89% |
| Income Tax Expense | 103.38M | 477.75M | 384.05M | 237.04M | 80.46M | 65.38M | 63.72M | 44.51M | 45.45M | 12.17M | 24.08M | 16.04M |
| Net Income | 643.38M | 2.75B | 2.22B | 1.51B | 402.33M | 233.32M | 188.51M | 170.04M | 131.43M | 31.26M | 52.45M | 44.09M |
| Net Income Ratio | 7.53% | 17.80% | 18.58% | 18.31% | 7.64% | 5.16% | 4.97% | 5.28% | 5.50% | 1.70% | 3.87% | 4.51% |
| EPS | 1.38 | 5.90 | 4.80 | 3.29 | 0.88 | 0.51 | 0.46 | 0.44 | 0.38 | 1.58 | 0.15 | 0.13 |
| EPS Diluted | 1.38 | 5.89 | 4.76 | 3.27 | 0.88 | 0.51 | 0.46 | 0.44 | 0.38 | 1.58 | 0.15 | 0.13 |
| Weighted Avg Shares Out | 466.22M | 466.57M | 462.43M | 458.88M | 457.88M | 457.49M | 409.79M | 386.44M | 342.26M | 345.87M | 345.87M | 345.87M |
| Weighted Avg Shares Out (Dil) | 466.22M | 467.37M | 466.31M | 461.68M | 457.88M | 457.49M | 409.79M | 386.44M | 345.87M | 345.87M | 345.87M | 345.87M |
Source: https://incomestatements.info
Category: Stock Reports